Critical Contrast: Nanovibronix (FEED) and Its Rivals

Nanovibronix (NASDAQ:FEED) is one of 27 public companies in the “Surgical, Medical, And Dental Instruments And Supplies” industry, but how does it compare to its rivals? We will compare Nanovibronix to similar businesses based on the strength of its earnings, dividends, profitability, valuation, analyst recommendations, risk and institutional ownership.

Profitability

This table compares Nanovibronix and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-275.12%	-24.78%	-19.24%
Nanovibronix Competitors	-569.68%	-122.96%	-53.63%

Volatility & Risk

Nanovibronix has a beta of 2.26, indicating that its stock price is 126% more volatile than the S&P 500. Comparatively, Nanovibronix’s rivals have a beta of 1.80, indicating that their average stock price is 80% more volatile than the S&P 500.

Earnings & Valuation

This table compares Nanovibronix and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nanovibronix	$2.56 million	-$3.70 million	-0.05
Nanovibronix Competitors	$61.19 million	-$32.64 million	5.16

Nanovibronix’s rivals have higher revenue, but lower earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of recent recommendations for Nanovibronix and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Nanovibronix Competitors	79	82	161	7	2.29

As a group, “Surgical, Medical, And Dental Instruments And Supplies” companies have a potential upside of 55.05%. Given Nanovibronix’s rivals stronger consensus rating and higher possible upside, analysts clearly believe Nanovibronix has less favorable growth aspects than its rivals.

Insider & Institutional Ownership

16.4% of Nanovibronix shares are held by institutional investors. Comparatively, 19.3% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by institutional investors. 1.4% of Nanovibronix shares are held by insiders. Comparatively, 19.5% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Nanovibronix rivals beat Nanovibronix on 8 of the 13 factors compared.

About Nanovibronix

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.